Home
Home

neutropenia

Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia

Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia
Yahoo

Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy

Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy
Pipeline Review

Teva reports positive Phase III blood disease trial results

Teva reports positive Phase III blood disease trial results
Globes, Israel

News

FDA delays ruling on Teva version of Amgen drug
Yahoo/AP
»